Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 136.25
-3.15 (-2.26%)
At close: Feb 12, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 6.48 billion as of February 13, 2026. Its market cap has decreased by -29.99% in one year.
Market Cap
6.48B
Enterprise Value
7.68B
Revenue
6.20B
Ranking
n/a
PE Ratio
39.31
Stock Price
136.25
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 6.48B, an increase of 1,033.28%. That is a compound annual growth rate of 10.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.48B | -10.44% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 9.96B |
| Fermenta Biotech | 9.16B |
| Wanbury | 9.05B |
| Fredun Pharmaceuticals | 8.89B |
| Anuh Pharma | 8.32B |
| Bharat Parenterals | 7.17B |
| Accent Microcell | 6.93B |
| Sudarshan Pharma Industries | 6.19B |